Uncoupling of endothelial NO synthase in atherosclerosis and vascular disease

Li, 2009, Prevention of atherosclerosis by interference with the vascular nitric oxide system, Curr Pharm Des, 15, 3133, 10.2174/138161209789058002 Forstermann, 2012, Nitric oxide synthases: regulation and function, Eur Heart J, 33, 829, 10.1093/eurheartj/ehr304 Crabtree, 2011, Dihydrofolate reductase protects endothelial nitric oxide synthase from uncoupling in tetrahydrobiopterin deficiency, Free Radic Biol Med, 50, 1639, 10.1016/j.freeradbiomed.2011.03.010 Pritchard, 1995, Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion, Circ Res, 77, 510, 10.1161/01.RES.77.3.510 Stepp, 2002, Native ldl and minimally oxidized ldl differentially regulate superoxide anion in vascular endothelium in situ, Am J Physiol Heart Circ Physiol, 283, H750, 10.1152/ajpheart.00029.2002 Alp, 2004, Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase i overexpression reduces endothelial dysfunction and atherosclerosis in apoe-knockout mice, Arterioscler Thromb Vasc Biol, 24, 445, 10.1161/01.ATV.0000115637.48689.77 Wohlfart, 2008, Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (enos) expression and preventing enos uncoupling, J Pharmacol Exp Ther, 325, 370, 10.1124/jpet.107.128009 Xia, 2010, Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein e knockout mice, J Pharmacol Exp Ther, 335, 149, 10.1124/jpet.110.168724 Heinloth, 2000, Stimulation of NADPH oxidase by oxidized low-density lipoprotein induces proliferation of human vascular endothelial cells, J Am Soc Nephrol, 11, 1819, 10.1681/ASN.V11101819 Rueckschloss, 2001, Induction of nad(p)h oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme a reductase inhibitor therapy, Circulation, 104, 1767, 10.1161/hc4001.097056 Steffen, 2012, Cigarette smoke and ldl cooperate in reducing nitric oxide bioavailability in endothelial cells via effects on both enos and NADPH oxidase, Nitric Oxide, 27, 176, 10.1016/j.niox.2012.06.006 Drummond, 2011, Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets, Nat Rev Drug Discov, 10, 453, 10.1038/nrd3403 Sorescu, 2002, Superoxide production and expression of nox family proteins in human atherosclerosis, Circulation, 105, 1429, 10.1161/01.CIR.0000012917.74432.66 Guzik, 2006, Coronary artery superoxide production and nox isoform expression in human coronary artery disease, Arterioscler Thromb Vasc Biol, 26, 333, 10.1161/01.ATV.0000196651.64776.51 Douglas, 2012, Endothelial-specific nox2 overexpression increases vascular superoxide and macrophage recruitment in apoe(−)/(−) mice, Cardiovasc Res, 94, 20, 10.1093/cvr/cvs026 Dikalova, 2010, Upregulation of nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via enos uncoupling, Am J Physiol Heart Circ Physiol, 299, H673, 10.1152/ajpheart.00242.2010 Forstermann, 2011, Therapeutic effect of enhancing endothelial nitric oxide synthase (enos) expression and preventing enos uncoupling, Br J Pharmacol, 164, 213, 10.1111/j.1476-5381.2010.01196.x Nickenig, 1999, Statin-sensitive dysregulated at1 receptor function and density in hypercholesterolemic men, Circulation, 100, 2131, 10.1161/01.CIR.100.21.2131 Chalupsky, 2005, Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase, Proc Natl Acad Sci U S A, 102, 9056, 10.1073/pnas.0409594102 Ponnuswamy, 2012, Enos protects from atherosclerosis despite relevant superoxide production by the enzyme in apoe mice, PLoS One, 7, e30193, 10.1371/journal.pone.0030193 Kauser, 2000, Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein e-deficient mice, Am J Physiol Heart Circ Physiol, 278, H1679, 10.1152/ajpheart.2000.278.5.H1679 Zhu, 2003, Low density lipoprotein induces enos translocation to membrane caveolae: the role of rhoa activation and stress fiber formation, Biochim Biophys Acta, 1635, 117, 10.1016/j.bbalip.2003.10.011 Feron, 1999, Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase, J Clin Invest, 103, 897, 10.1172/JCI4829 Pritchard, 2002, Native low-density lipoprotein induces endothelial nitric oxide synthase dysfunction: role of heat shock protein 90 and caveolin-1, Free Radic Biol Med, 33, 52, 10.1016/S0891-5849(02)00851-1 Chavakis, 2001, Oxidized ldl inhibits vascular endothelial growth factor-induced endothelial cell migration by an inhibitory effect on the akt/endothelial nitric oxide synthase pathway, Circulation, 103, 2102, 10.1161/01.CIR.103.16.2102 Ryoo, 2011, Oxldl-dependent activation of arginase II is dependent on the lox-1 receptor and downstream rhoa signaling, Atherosclerosis, 214, 279, 10.1016/j.atherosclerosis.2010.10.044 Sindler, 2009, Effects of ageing and exercise training on enos uncoupling in skeletal muscle resistance arterioles, J Physiol, 587, 3885, 10.1113/jphysiol.2009.172221 Imanishi, 2008, Addition of eplerenone to an angiotensin-converting enzyme inhibitor effectively improves nitric oxide bioavailability, Hypertension, 51, 734, 10.1161/HYPERTENSIONAHA.107.104299 Warnholtz, 1999, Increased nadh-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin–angiotensin system, Circulation, 99, 2027, 10.1161/01.CIR.99.15.2027 Takaya, 2006, Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein e-deficient mice, Atherosclerosis, 186, 402, 10.1016/j.atherosclerosis.2005.08.009 Wenzel, 2008, At1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase i and protects enos in diabetic rats, Free Radic Biol Med, 45, 619, 10.1016/j.freeradbiomed.2008.05.009 Satoh, 2008, Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy, Nephrol Dial Transplant, 23, 3806, 10.1093/ndt/gfn357 Oak, 2007, Attenuation of angiotensin II signaling recouples enos and inhibits nonendothelial nox activity in diabetic mice, Diabetes, 56, 118, 10.2337/db06-0288 Knorr, 2011, Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and s-glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the at1 receptor blocker telmisartan, Arterioscler Thromb Vasc Biol, 31, 2223, 10.1161/ATVBAHA.111.232058 Antonopoulos, 2012, Statins as anti-inflammatory agents in atherogenesis: Molecular mechanisms and lessons from the recent clinical trials, Curr Pharm Des, 18, 1519, 10.2174/138161212799504803 Hattori, 2003, Hmg-coa reductase inhibitor increases GTP cyclohydrolase i mrna and tetrahydrobiopterin in vascular endothelial cells, Arterioscler Thromb Vasc Biol, 23, 176, 10.1161/01.ATV.0000054659.72231.A1 Wenzel, 2008, Mechanisms underlying recoupling of enos by hmg-coa reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus, Atherosclerosis, 198, 65, 10.1016/j.atherosclerosis.2007.10.003 Antoniades, 2011, Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling, Circulation, 124, 335, 10.1161/CIRCULATIONAHA.110.985150 Antoniades, 2010, Preoperative atorvastatin treatment in cabg patients rapidly improves vein graft redox state by inhibition of rac1 and NADPH-oxidase activity, Circulation, 122, S66, 10.1161/CIRCULATIONAHA.109.927376 Carrepeiro, 2011, Effect of n−3 fatty acids and statins on oxidative stress in statin-treated hypercholestorelemic and normocholesterolemic women, Atherosclerosis, 217, 171, 10.1016/j.atherosclerosis.2010.12.013 Landmesser, 2005, Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans, Circulation, 111, 2356, 10.1161/01.CIR.0000164260.82417.3F Munzel, 2009, Nebivolol: the somewhat-different beta-adrenergic receptor blocker, J Am Coll Cardiol, 54, 1491, 10.1016/j.jacc.2009.05.066 Mollnau, 2003, Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells, Arterioscler Thromb Vasc Biol, 23, 615, 10.1161/01.ATV.0000065234.70518.26 Oelze, 2006, Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats, Hypertension, 48, 677, 10.1161/01.HYP.0000239207.82326.29 Oppermann, 2009, Pharmacological induction of vascular extracellular superoxide dismutase expression in vivo, J Cell Mol Med, 13, 1271, 10.1111/j.1582-4934.2008.00627.x Schuhmacher, 2011, Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapy, Diabetes, 60, 2608, 10.2337/db10-1395 Li, 2012, Cardiovascular effects and molecular targets of resveratrol, Nitric Oxide, 26, 102, 10.1016/j.niox.2011.12.006 Do, 2008, Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo e-deficient mice, Biochem Biophys Res Commun, 374, 55, 10.1016/j.bbrc.2008.06.113 Timmers, 2011, Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans, Cell Metab, 14, 612, 10.1016/j.cmet.2011.10.002 Klinge, 2008, Resveratrol stimulates nitric oxide production by increasing estrogen receptor alpha-src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells, FASEB J, 22, 2185, 10.1096/fj.07-103366 Mattagajasingh, 2007, Sirt1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase, Proc Natl Acad Sci U S A, 104, 14855, 10.1073/pnas.0704329104 Cunnington, 2012, Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease, Circulation, 125, 1356, 10.1161/CIRCULATIONAHA.111.038919 McNeill, 2012, The role of tetrahydrobiopterin in inflammation and cardiovascular disease, Thromb Haemost, 108 Youn, 2012, Endothelium-specific sepiapterin reductase deficiency in doca-salt hypertension, Am J Physiol Heart Circ Physiol, 302, H2243, 10.1152/ajpheart.00835.2011 Westermann, 2009, Enhancement of the endothelial no synthase attenuates experimental diastolic heart failure, Basic Res Cardiol, 104, 499, 10.1007/s00395-009-0014-6 Yang, 2011, Ave3085, an enhancer of endothelial nitric oxide synthase, restores endothelial function and reduces blood pressure in spontaneously hypertensive rats, Br J Pharmacol, 163, 1078, 10.1111/j.1476-5381.2011.01308.x Cheang, 2011, Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db/db mice, Cardiovasc Res, 92, 267, 10.1093/cvr/cvr233